Target intelligence / Profile preview

SMG1 pseudogene 4 (SMG1P4)

Target
SMG1P4
Molecular classification
Other (pseudogene)
01

Overview

SMG1 pseudogene 4 (SMG1P4) is a pseudogene that arises from the SMG1 gene, which encodes a phosphatidylinositol 3-kinase-related kinase (PIKK) involved in nonsense-mediated mRNA decay (NMD) and cellular responses to stress [1][2][3]. However, SMG1P4 itself is categorized as a non-coding pseudogene and does not represent a protein-coding gene or known therapeutic target, nor does it have direct molecular or pharmacological relevance. There is currently no evidence that SMG1P4 is transcribed into a functional RNA product or protein, nor is there an established role in disease, biomarker status, or drug interaction. SMG1 (not the pseudogene) is a functionally important kinase and therapeutic target, but SMG1P4 should not be considered a target molecule in the conventional sense[1][2][3]. Key note: If your intent was to find information on SMG1 (the enzyme/kinase), refer instead to the canonical protein-coding gene “SMG1 phosphatidylinositol 3-kinase-related kinase,” which has established roles in NMD, genotoxic stress response, and tumor suppression, unlike its pseudogenes[1][2][3].

Other names
SMG1P4SMG1 phosphatidylinositol 3-kinase-related kinase pseudogeneNonsense mediated mRNA decay associated PI3K related kinase pseudogene 4SMG-1 homolog, phosphatidylinositol 3-kinase-related kinase pseudogene
02

Biological functions

Other (no known direct biological function; processed pseudogene)
03

Disease associations

Other (no established disease association)

Beyond the preview

Go deeper on SMG1 pseudogene 4 (SMG1P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMG1 pseudogene 4 (SMG1P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call